FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 344:673 March 1, 2001 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

The American health care system remains a paradox of abundance and weaknesses.¹ It is the most expensive health care system in the developed world. Its academic medical centers deliver sophisticated care to patients with complex and serious illnesses. The United States is also a leader in developing new forms of medical technology and new medications. Although these innovations have had substantial benefits for health, they have also contributed to soaring health care costs. In addition, there is starvation in the midst of plenty: more than 40 million people lack health insurance, and millions of insured have inadequate coverage. Thus, many . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Hull, R., Pineo, G., Landow, L., Turpie, A. G.G., Gallus, A. S., Hoek, J. A. (2001). A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis. NEJM 345: 291-292 [Full Text]  
• (2001). A New Alternative to Heparin. Journal Watch Cardiology 2001: 11-11 [Full Text]  
• (2001). A New Alternative to Heparin. JWatch General 2001: 3-3 [Full Text]